# Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe Asthma

> **NCT06740045** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Dr. Andrew Thamboo, MD** · enrollment: 10 (estimated)

## Conditions studied

- Asthma
- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **BIOLOGICAL:** Tezepelumab

## Key facts

- **NCT ID:** NCT06740045
- **Lead sponsor:** Dr. Andrew Thamboo, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2025-03
- **Final completion:** 2025-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06740045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06740045, "Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06740045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*